News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
ter Meulen Jan Henrik
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/04/2019 |
4
| ter Meulen Jan Henrik (Chief Scientific Officer) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 14,620 shares
@ $5.85, valued at
$85.5k
Disposed/sold 69,362 restricted stock units
@ $0
Disposed/sold 98,837 options to buy
@ $1.23, valued at
$121.6k
Disposed/sold 70,000 options to buy
@ $5.6, valued at
$392k
Disposed/sold 90,000 options to buy
@ $4.05, valued at
$364.5k
Disposed/sold 46,788 options to buy
@ $4.4, valued at
$205.9k
Disposed/sold 120,000 options to buy
@ $1.31, valued at
$157.2k
|
|
| 01/07/2019 |
4
| ter Meulen Jan Henrik (Chief Scientific Officer) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 25,000 shares
@ $0
Sold 3,414 shares
@ $1.586, valued at
$5.4k
Granted 120,000 options to buy
@ $1.31, valued at
$157.2k
|
|
| 11/09/2018 |
4
| ter Meulen Jan Henrik (Chief Scientific Officer) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 23,362 shares
@ $0 |
|
| 07/19/2018 |
4
| ter Meulen Jan Henrik (Chief Scientific Officer) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 2,493 options to buy
@ $31, valued at
$77.3k
Granted 1,247 options to buy
@ $4.4, valued at
$5.5k
Disposed/sold 22,507 options to buy
@ $31, valued at
$697.7k
Granted 11,254 options to buy
@ $4.4, valued at
$49.5k
Disposed/sold 5,574 options to buy
@ $19.39, valued at
$108.1k
Granted 3,186 options to buy
@ $4.4, valued at
$14k
Disposed/sold 54,426 options to buy
@ $19.39, valued at
$1.1M
Granted 31,101 options to buy
@ $4.4, valued at
$136.8k
|
|
| 01/08/2018 |
4
| ter Meulen Jan Henrik (Chief Scientific Officer) has filed a Form 4 on Immune Design Corp.|
Txns:
| Granted 18,000 shares
@ $0
Sold 1,986 shares
@ $4.17, valued at
$8.3k
Granted 90,000 options to buy
@ $4.05, valued at
$364.5k
|
|
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|